EARLY LIFE THREATENING THROMBOCYTOPENIA UNRELATED TO BONE MARROW SUPPRESSION SECONDARY TO ACTINOMYCIN-D (ACT-D) IN FIVE PEDIATRIC SOLID TUMOR PATIENTS SUCCESSFULLY TREATED WITH PREDNISONE THERAPY | Zendy

AI Assistant Blog Pricing

EARLY LIFE THREATENING THROMBOCYTOPENIA UNRELATED TO BONE MARROW SUPPRESSION SECONDARY TO ACTINOMYCIN-D (ACT-D) IN FIVE PEDIATRIC SOLID TUMOR PATIENTS SUCCESSFULLY TREATED WITH PREDNISONE THERAPY

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.